NIH funds research on pan-coronavirus vaccines
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today awarded grants to Brigham and Women’s Hospital and two universities to research and develop vaccine candidates that provide broad protective immunity to multiple coronavirus strains.
“These new awards are designed to look ahead and prepare for the next generation of coronaviruses with pandemic potential,” said NIAID Director Anthony Fauci, M.D.
The Pan-Coronavirus Vaccine Development Program expects to award additional grants to projects in 2022.
Related News Articles
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
During its 2025 Annual Membership Meeting May 5 in Washington, D.C., the AHA honored several health care leaders including:Award for Excellence to Patricia…
Headline
Health delivery organizations are encouraged to apply by 1 p.m. ET May 6 for the AHA’s 2026 Foster G. McGaw Prize, honoring organizations that demonstrate…
Headline
Hospitals and health systems are urged to nominate candidates as soon as possible for the AHA Next Generation Leaders Fellowship so they can apply by the March…
Headline
Ian Morrison, a highly regarded author, consultant and futurist, died last week. He specialized in long-term forecasting and planning with a particular…
Headline
To navigate a shifting landscape of technologies, care models and patient needs, hospitals and health systems need to develop future leaders who are ready to…